BNTC

Quote

Short

News

Articles

Message Board

Benitec Biopharma launches public, registered direct offerings

November 05, 2025 05:03:41 pm

Source: SeekingAlpha

2025-11-05 17:03:41 ET

More on Benitec Biopharma

Read the full article on Seeking Alpha

For further details see:

Benitec Biopharma launches public, registered direct offerings

Benitec Biopharma Inc.

NASDAQ: BNTC

BNTC Trading

-2.4% G/L:

$10.58 Last:

9,537 Volume:

$10.96 Open:

mwn-ir Ad 300

BNTC Latest News

May 14, 2026 08:00:00 am

Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update

April 28, 2026 07:00:00 am

Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting

March 10, 2026 07:00:00 am

Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development f

March 09, 2026 07:00:00 am

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

BNTC Stock Data

Market Cap $403,180,255

Float 15,517,473

Insiders Ownership 0.09%

Institutions 20

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.benitec.com

Country US

City Hayward

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App